NovaBay Pharmaceuticals, Inc. (NBY) financial statements (2021 and earlier)

Company profile

Business Address 2000 POWELL STREET, SUITE 1150
EMERYVILLE, CA 94608
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments127331025
Cash and cash equivalents127331025
Receivables1134210
Inventory, net of allowances, customer advances and progress billings1001111
Inventory1001111
Prepaid expense0000201
Other current assets0000  5
Other undisclosed current assets0111  (5)
Total current assets:149991457
Noncurrent Assets
Operating lease, right-of-use asset01
Property, plant and equipment0000000
Other noncurrent assets0011100
Total noncurrent assets:1211111
TOTAL ASSETS:15119101558
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2242243
Accounts payable0010022
Accrued liabilities2232221
Deferred revenue 0
Debt 2     
Derivative instruments and hedges, liabilities 0     
Deferred revenue and credits3200
Contract with customer, liability2
Other undisclosed current liabilities01(2)    
Total current liabilities:3645453
Noncurrent Liabilities
Long-term debt and lease obligation01     
Operating lease, liability01
Liabilities, other than long-term debt  01342
Deferred revenue and credits1222
Deferred rent credit  0
Other liabilities  00010
Other undisclosed noncurrent liabilities(0)40112 
Total noncurrent liabilities:0513462
Total liabilities:310478106
Stockholders' equity
Stockholders' equity attributable to parent, including:121537(5)73
Common stock0000001
Additional paid in capital1481261201141118573
Accumulated deficit(136)(125)(115)(111)(104)(91) 
Warrants and rights outstanding   1   
Other undisclosed stockholders' equity attributable to parent   (1)   
Other undisclosed stockholders' equity      (72)
Total stockholders' equity:121537(5)2
TOTAL LIABILITIES AND EQUITY:15119101558

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues10713181240
Revenue, net181241
Cost of revenue
(Cost of Goods and Services Sold)
(4)(2)(2)(3)(2)(1)(0)
Other undisclosed gross profit      0
Gross profit:651115930
Operating expenses(12) (19)(23)(20)(24)(17)
Other undisclosed operating income      0
Operating income (loss):(6)5(8)(7)(11)(21)(17)
Nonoperating income (expense)1 00(2)22
Investment income, nonoperating    (2)22
Other nonoperating income (expense)1 00(0)(0)0
Interest and debt expense (0)     
Income (loss) from continuing operations before equity method investments, income taxes:(6)5(8)(7)(13)(19)(15)
Other undisclosed income (loss) from continuing operations before income taxes(5)(14)1(0)   
Loss from continuing operations before income taxes:(11)(10)(7)(7)(13)(19)(15)
Income tax expense(0) (0)(0)(0)(0)(0)
Loss before gain (loss) on sale of properties:(11)(10)(7)(7)(13)(19)(15)
Other undisclosed net loss     (0) 
Net loss:(11)(10)(7)(7)(13)(19)(15)
Other undisclosed net loss attributable to parent (0)     
Net loss attributable to parent:(11)(10)(7)(7)(13)(19)(15)
Preferred stock dividends and other adjustments (1)     
Net loss available to common stockholders, basic:(11)(10)(7)(7)(13)(19)(15)
Dilutive securities, effect on basic earnings per share  (1)    
Net loss available to common stockholders, diluted:(11)(10)(8)(7)(13)(19)(15)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(11)(10)(7)(7)(13)(19)(15)
Comprehensive loss:(11)(10)(7)(7)(13)(19)(15)
Other undisclosed comprehensive income, net of tax, attributable to parent      0
Comprehensive loss, net of tax, attributable to parent:(11)(10)(7)(7)(13)(19)(15)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: